Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Documents (9878)

Showing 12 of 9878 View All
Showing 158 of 824 pages

Gavi Risk and Assurance Report 2020

This annual Risk & Assurance Report discusses the most critical risks that could potentially have an impact on the ability of the Alliance to achieve its mission and strategic goals. This year’s report presents a reframed set of 16 top risks in the context of Gavi 5.0, the COVID-19 pandemic and the COVAX Facility.

08 COVAX Facility operationalisation and vaccine programme Presentation pdf

www.gavi.org
Reach every child
COVAX FACILITY
OPERATIONALISATION AND
VACCINE PROGRAMME
BOARD MEETING
Aur?lia Nguyen
15-17 December 2020, Virtual Meeting
COVAX Facility Update
2
Board meeting
15-17 December 2020

02 Finance Presentation pdf

www.gavi.org
FINANCE
BOARD MEETING
Assietou Diouf
15-17 December 2020, Virtual Meeting
Board meeting
15-17 December 2020
EXECUTIVE SUMMARY
Sufficient Resources to fund current and future Board decisions for 5.0
Qualifying
Resources
Expenditures
Net available for
future investments
Investments for
Decision Today
US$ 9.5 bn
US$ 9.2 bn
US$ 0.3 bn
US$ 10.4 bn
US$ 9.3 bn
US$ 0.7 bn
US$ 0.4 bn
2016-2020 2021-2025
1. 2016-2020 Gavi 4.0
? Delivered within 1% budget despite
COVID-19
2. 2021-2025 Gavi 5.0
? Successful replenishment and US$ 1.2 bn
still available for future investments
3. Proposed Investments
? US$ 0.7 bn prioritised
4. Secretariat
5. Partners? Engagement Framework (PEF)
6. Recommendations
2
Excluding COVAX AMC and Self Financing
resources & expenditures

07 MICs Presentation pdf

www.gavi.org
Reach every child
Gavi?s approach to
engagement with former
and never-eligible Middle
Income Countries (MICs)
BOARD MEETING
Santiago Cornejo
15-17 December 2020, Virtual Meeting
The objectives of the MICs Approach address key threats to
sustainability and equity, which are core to Gavi 5.0
2
Board meeting
15-17 December 2020
1. Over the first 6 months of the year. Preliminary data. W HO Administrative Data Estimates for DTP3, November
2020. 2. Includes never-Gavi MICs with GNI p.c. $6,000 and additional never-Gavi IDA eligible economies.
Note: In this presentation, the acronyms ?MIC?, ?LMIC?, and ?UMIC? , and the word ?countries? include economies
that are not UN member states.
Challenges
MICs Objectives
Given the relevance of these threats to the successful delivery of Gavi 5.0, it is critical to
move forward on the MICs agenda now
.
Risk of backsliding, heightened by the pandemic,
threatens Gavi legacy and exacerbates inequities
? E.g., 8 former Gavis have seen a decrease in
number of children vaccinated in 2020 vs. 2019
1
Prevent and mitigate
backsliding in former Gavi-
eligible countries
Drive sustainable
introductions of key
missing vaccines in former
and never Gavi-eligible
countries
MICs are missing critical vaccine introductions , and
never-Gavis lag behind former-Gavis with similar income
levels
? E.g., 8 never-Gavi MICs are missing all three of
PCV, rotavirus, and HPV vaccines, and 11 are
missing two of the three
2

Subscribe to our newsletter